Table 3.
Concentrations of genistein and daidzein in serum in the two groups
Group | Genistein (µmol/L) | Daidzein (µmol/L) | |
---|---|---|---|
Group I (n = 37) | Before taking isoflavone | 0.38 ± 0.96 | 0.09 ± 0.43 |
After taking isoflavone | 4.14 ± 4.03* | 1.15 ± 1.16* | |
Group II (n = 33) | Before taking isoflavone | 0.32 ± 0.75 | 0.06 ± 0.22 |
After taking isoflavone | 0.30 ± 0.76 | 0.09 ± 0.48 |
Concentrations of genistein and daidzein in serum of subjects in isoflavone group and placebo group after 6 months of treatment with soy isoflavone 90 mg/day. Experimental conditions and treatment procedures are given in Materials and Methods. Graph depicts (mean ± SD). Asterisk means significant against baseline before trial (*p<0.05), t test.